These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12916908)

  • 1. The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets.
    Leane MM; Cumming I; Corrigan OI
    AAPS PharmSciTech; 2003; 4(2):E26. PubMed ID: 12916908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial neural networks in the optimization of a nimodipine controlled release tablet formulation.
    Barmpalexis P; Kanaze FI; Kachrimanis K; Georgarakis E
    Eur J Pharm Biopharm; 2010 Feb; 74(2):316-23. PubMed ID: 19815063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-releasing cochlear implant coatings: application of artificial neural networks for modelling of formulation parameters and drug release profile.
    Nemati P; Imani M; Farahmandghavi F; Mirzadeh H; Marzban-Rad E; Nasrabadi AM
    J Pharm Pharmacol; 2013 Aug; 65(8):1145-57. PubMed ID: 23837582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on influence of Wurster coating process parameters for the development of delayed release minitablets of Naproxen.
    Shah N; Mehta T; Aware R; Shetty V
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1989-1998. PubMed ID: 28737435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience.
    Dowell JA; Hussain A; Devane J; Young D
    J Pharm Sci; 1999 Jan; 88(1):154-60. PubMed ID: 9874718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Artificial neural network parameters optimization software and its application in the design of sustained release tablets].
    Zhang XY; Chen DW; Jin J; Lu W
    Yao Xue Xue Bao; 2009 Oct; 44(10):1159-64. PubMed ID: 20055142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks for bilateral prediction of formulation parameters and drug release profiles from cochlear implant coatings fabricated as porous monolithic devices based on silicone rubber.
    Nemati P; Imani M; Farahmandghavi F; Mirzadeh H; Marzban-Rad E; Nasrabadi AM
    J Pharm Pharmacol; 2014 May; 66(5):624-38. PubMed ID: 24341981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of metformin HCl 500 mg sustained release matrix tablets using Artificial Neural Network (ANN) based on Multilayer Perceptrons (MLP) model.
    Mandal U; Gowda V; Ghosh A; Bose A; Bhaumik U; Chatterjee B; Pal TK
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):150-5. PubMed ID: 18239298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic development of pH-independent controlled release tablets of carvedilol using central composite design and artificial neural networks.
    Aktas E; Eroglu H; Kockan U; Oner L
    Drug Dev Ind Pharm; 2013 Aug; 39(8):1207-16. PubMed ID: 22804226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimize the preparation process of Erigeron breviscapus sustained-release pellets based on artificial neural network and particle swarm optimization algorithm].
    Zhang JX; Chen YZ; Wu ZN; Liao WR
    Zhong Yao Cai; 2012 Jan; 35(1):127-33. PubMed ID: 22734423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relating formulation variables to in vitro dissolution using an artificial neural network.
    Ebube NK; McCall T; Chen Y; Meyer MC
    Pharm Dev Technol; 1997 Aug; 2(3):225-32. PubMed ID: 9552450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release control and system understanding of sucrose esters matrix tablets by artificial neural networks.
    Chansanroj K; Petrović J; Ibrić S; Betz G
    Eur J Pharm Sci; 2011 Oct; 44(3):321-31. PubMed ID: 21878388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm.
    Plumb AP; Rowe RC; York P; Brown M
    Eur J Pharm Sci; 2005; 25(4-5):395-405. PubMed ID: 15893460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training artificial neural networks directly on the concordance index for censored data using genetic algorithms.
    Kalderstam J; Edén P; Bendahl PO; Strand C; Fernö M; Ohlsson M
    Artif Intell Med; 2013 Jun; 58(2):125-32. PubMed ID: 23582884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of dissolution profiles of acetaminophen beads using artificial neural networks.
    Peng Y; Geraldrajan M; Chen Q; Sun Y; Johnson JR; Shukla AJ
    Pharm Dev Technol; 2006; 11(3):337-49. PubMed ID: 16895844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of sponge-like acyclovir ocular minitablets.
    Refai H; Tag R
    Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.